Your browser doesn't support javascript.
loading
Short-term exposure of dairy cows to pyrrolizidine alkaloids from tansy ragwort (Jacobaea vulgaris Gaertn.): effects on organs and indicators of energy metabolism.
Knoop, Kirsten; Frahm, Jana; Kersten, Susanne; Kluess, Jeannette; Meyer, Ulrich; von Soosten, Dirk; Beineke, Andreas; Saltzmann, Janine; Dänicke, Sven.
Afiliação
  • Knoop K; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Frahm J; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Kersten S; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Kluess J; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Meyer U; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • von Soosten D; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Beineke A; Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Saltzmann J; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
  • Dänicke S; Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Braunschweig, Germany.
Arch Anim Nutr ; 78(2): 109-124, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38796745
ABSTRACT
Preserved feed from meadows contaminated with ragwort (Jacobaea vulgaris, Gaertn.) may expose livestock to pyrrolizidine alkaloids (PA). Dairy cows are considered to be very susceptible animals and a PA ingestion can lead to liver and further organ damages and even death. Due to the lack of data, the present study aimed to evaluate critical PA doses based on organ effects, with a special focus on liver lesions and on indicators of energy metabolism. Therefore, 16 dairy cows (n = 4 per group) were exposed to increasing PA doses (group CONMolasses <0.001 mg PA/kg body weight (BW)/day (d); PA1 0.47 mg PA/kg BW/d; PA2 0.95 mg PA/kg BW/d; PA3 1.91 mg PA/kg BW/d) for 28 days. Constant dosing was ensured by a defined PA extract administered orally once daily. Histological examinations of the livers showed infiltration by immune cells, higher proportions of apoptotic cells and enlargement of hepatocyte nuclei in the highest exposed group. In addition, bile volume increased with PA dose, which may indicate a cholestasis. Despite the signs of incipient liver damage, liver lipid content and clinical chemical parameters related to energy metabolism, such as glucose, non-esterified fatty acids and ßhydroxybutyrate, remained unaffected. Fat depot masses were also not significantly altered over time, suggesting that PA exposure did not induce a wasting syndrome. The liver showed slight microscopic changes already at a dosage of 0.95 mg PA/kg BW/d. However, the short-term metabolic indicators of energy status, lipolysis and ketogenesis, glucose, NEFA and BHB, as well as changes in fat depot, which serves as a longer-term indicator of lipolysis, remained unaffected in all treatment groups in the chosen scenario. These findings suggest that despite histopathological and clinical-chemical evidence of PA-associated hepatocellular lesions, liver function was not compromised.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alcaloides de Pirrolizidina / Metabolismo Energético Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alcaloides de Pirrolizidina / Metabolismo Energético Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article